Search research articles
Contact Us
Filters
Showing results (131-140 of 220) with videos related to
Page
of 22
Sort By:
British Journal of Pharmacology
|
January 15, 2021
The ratio of ursodeoxycholyltaurine to 7-oxolithocholyltaurine serves as a biomarker of decreased 11β-hydroxysteroid dehydrogenase 1 activity in mouse
Michael Weingartner, Simon Stücheli, Denise V Kratschmar, et al.
The Biochemical Journal
|
April 2, 2011
Hepatic reduction of the secondary bile acid 7-oxolithocholic acid is mediated by 11β-hydroxysteroid dehydrogenase 1
Alex Odermatt, Thierry Da Cunha, Carlos A Penno, et al.
Journal of Molecular Endocrinology
|
August 10, 2005
Comparative enzymology of 11beta-hydroxysteroid dehydrogenase type 1 from six species
Spyridon Arampatzis, Bert Kadereit, Daniela Schuster, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 19, 2004
Compound library development guided by protein structure similarity clustering and natural product structure
Marcus A Koch, Lars-Oliver Wittenberg, Sudipta Basu, et al.
American Journal of Physiology. Renal Physiology
|
September 4, 2015
Rab-GAP TBC1D4 (AS160) is dispensable for the renal control of sodium and water homeostasis but regulates GLUT4 in mouse kidney
Marianna Di Chiara, Bob Glaudemans, Dominique Loffing-Cueni, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
January 18, 2011
Characterization of activity and binding mode of glycyrrhetinic acid derivatives inhibiting 11β-hydroxysteroid dehydrogenase type 2
Denise V Kratschmar, Anna Vuorinen, Thierry Da Cunha, et al.
European Journal of Medicinal Chemistry
|
December 6, 2017
Accelerated skin wound healing by selective 11β-Hydroxylase (CYP11B1) inhibitors
Juliette Emmerich, Chris J van Koppen, Jens L Burkhart, et al.
Fitoterapia
|
June 19, 2009
Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 by plant extracts used as traditional antidiabetic medicines
Christel Gumy, Carmen Thurnbichler, Evelyne M Aubry, et al.
Frontiers in Immunology
|
June 19, 2025
Elucidation of B-cell specific drug immunogenicity liabilities via a novel <i>ex vivo</i> assay
Cary M Looney, Axel Ducret, Guido Steiner, et al.
American Journal of Physiology. Renal Physiology
|
November 8, 2013
Effect of chronic renal failure on the hepatic, intestinal, and renal expression of bile acid transporters
Zhibo Gai, Lei Chu, Christian Hiller, et al.
Page
of 22
Search research articles
Search
Showing results (131-140 of 220) with videos related to
Sort By:
Page
of 22
British Journal of Pharmacology
|
January 15, 2021
The ratio of ursodeoxycholyltaurine to 7-oxolithocholyltaurine serves as a biomarker of decreased 11β-hydroxysteroid dehydrogenase 1 activity in mouse
Michael Weingartner, Simon Stücheli, Denise V Kratschmar, et al.
The Biochemical Journal
|
April 2, 2011
Hepatic reduction of the secondary bile acid 7-oxolithocholic acid is mediated by 11β-hydroxysteroid dehydrogenase 1
Alex Odermatt, Thierry Da Cunha, Carlos A Penno, et al.
Journal of Molecular Endocrinology
|
August 10, 2005
Comparative enzymology of 11beta-hydroxysteroid dehydrogenase type 1 from six species
Spyridon Arampatzis, Bert Kadereit, Daniela Schuster, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 19, 2004
Compound library development guided by protein structure similarity clustering and natural product structure
Marcus A Koch, Lars-Oliver Wittenberg, Sudipta Basu, et al.
American Journal of Physiology. Renal Physiology
|
September 4, 2015
Rab-GAP TBC1D4 (AS160) is dispensable for the renal control of sodium and water homeostasis but regulates GLUT4 in mouse kidney
Marianna Di Chiara, Bob Glaudemans, Dominique Loffing-Cueni, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
January 18, 2011
Characterization of activity and binding mode of glycyrrhetinic acid derivatives inhibiting 11β-hydroxysteroid dehydrogenase type 2
Denise V Kratschmar, Anna Vuorinen, Thierry Da Cunha, et al.
European Journal of Medicinal Chemistry
|
December 6, 2017
Accelerated skin wound healing by selective 11β-Hydroxylase (CYP11B1) inhibitors
Juliette Emmerich, Chris J van Koppen, Jens L Burkhart, et al.
Fitoterapia
|
June 19, 2009
Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 by plant extracts used as traditional antidiabetic medicines
Christel Gumy, Carmen Thurnbichler, Evelyne M Aubry, et al.
Frontiers in Immunology
|
June 19, 2025
Elucidation of B-cell specific drug immunogenicity liabilities via a novel <i>ex vivo</i> assay
Cary M Looney, Axel Ducret, Guido Steiner, et al.
American Journal of Physiology. Renal Physiology
|
November 8, 2013
Effect of chronic renal failure on the hepatic, intestinal, and renal expression of bile acid transporters
Zhibo Gai, Lei Chu, Christian Hiller, et al.
Page
of 22